Skip to Content

Bioeconomy initiative

Accelerating the global transition to a bio-based economy

The time is now for biosolutions. Industries are recognizing the breakthrough potential of engineering biology techniques, which harness the power of natural biological processes to address critical planetary challenges. These innovations are essential for a healthy, prosperous, and sustainable future. They allow us to reimagine supply chains and economies globally, reshaping industries at every level. However, despite their revolutionary potential, biosolutions are rarely reaching the commercial mainstream.

As a strategic partner of the World Economic Forum, Capgemini has been co-leading the Forum’s Bioeconomy Initiative. This initiative has built a multi-stakeholder community to foster dialogue and collaboration across industries, sectors, and economies, driving forward innovation and unlocking value.

Latest reports

Next generation bio-innovation: Delivering commercial value

Biology is poised to drive commercial value. A shift towards differentiated value creation can transform the bioeconomy.

This latest paper from the World Economic Forum in collaboration with Capgemini dives into how biology can revolutionize industries and drive commercial success. 

Download the brochure here

From policy to practice: Actionable recommendations for a commercial bioeconomy

Global trade disruptions and sustainability pressures are accelerating the need for resilient, bio-based industries. While more than 50 national bioeconomy strategy frameworks have emerged worldwide, many remain visionary, lacking the concrete implementation plans needed to drive real-world impact.

This report uncovers a critical disconnect: technological innovation is advancing rapidly, yet commercialization continues to lag.

Download on the Forum’s website
weF Report Accelerating the Tech Driven BioEconomy book

Accelerating the tech-driven bioeconomy

The time is ripe for a global transition to a bio-based economy. Powered by the ever-evolving capacity to read, write, edit and increasingly functionalize deoxyribonucleic acid (DNA), the tech-enabled bioeconomy promises fundamental improvements in everyday life.

Digital advances are also expanding the areas where biology can deliver impact, and generative biology is set to disrupt several industries. Yet, despite decades of investment and technological progress, as well as sanguine market projections, the global transition to a bio-based economy has yet to enter the commercial mainstream.

Download on the Forum’s website

Insights from Davos 2025

In the midst of growing technological convergence, where hybrid AI meets R&D and design meets data, we believe intelligent collaboration will deliver true impact and value for all.

Read more

    Insights from Davos 2024

    When digital meets physical, when Gen AI meets creativity, and when sustainability meets scalability, you can truly unlock the value of tech for your business.

    Read more

      Insights from Davos 2023

      The future of industry will be more intelligent, efficient, sustainable, and resilient.

      Read more

        Related content

        Initiative

        Our flagship initiative to accelerate the transition to a bioeconomy

        Read more about our flagship initiative to accelerate the global transition to a bio-based economy on the World Economic Forum’s website.

        Video

        The bioeconomy in our daily lives

        Learn more about building a bioeconomy that improves health, prosperity and planetary balance.

        Blog

        Biotechnology: Transforming healthcare and our planet

        The path to sustainable, scalable alternatives to some of the most pressing, climate change-induced challenges.

        White paper

        Accelerating the global transition to a bio-based economy

        The strategic role of policy  in ensuring that innovation delivers a human-centred and resilient bio-based economy.

        Related offer

        Engineering biology

        Advances in Engineering Biology, sometimes known as synthetic biology, are unlocking a new industrial revolution to meet economic, environmental

        Read more

        Subscribe to ‘Straight to the future’

        Each month, delve into the latest industry insights. Don’t just keep up, stay ahead of the curve with our exclusive newsletter.

        Subscribe on LinkedIn

        Meet our experts

        Richard Traherne

        Capgemini Invent | World Economic Forum Bioeconomy Steering Group Member
        Richard shapes new strategic business areas at Capgemini Invent, bringing together its market-leading innovation services to create next frontiers.

        Dr. Cassandra Padbury

        Associate Director, Technology Strategy at Cambridge Consultants, part of Capgemini Invent
        Cassi identifies opportunities and realises the value of ideas. With over 20 years in R&D and deeptech consulting, she helps clients deliver impact by foreseeing change and taking advantage of technology. Working across FMCG, healthcare, energy and industrial sectors she leads projects to enable our clients to meet their strategic ambitions.

        Dr. Christopher Yates

        World Economic Forum Fellow on the Bioeconomy Initiative
        Chris helps companies understand the emerging and disruptive technology trends and how these can be leveraged to drive transformative change for their business and industry. He has a strong focus on Industrial Biotechnology and sustainability and how to realise opportunities across the end-to-end value chain. He brings strong multi-sector experience to take a variety of clients from a vision to developing innovative technology that delivers against their strategy.

          Learn more

          Initiatives and research with the World Economic Forum

          As a strategic partner of the World Economic Forum, we engage with the Forum to develop solutions to the world’s most pressing challenges.